Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis

This study comprehensively evaluates the magnitude of the effect of different DMTs on blood immune cells providing a better understanding of therapy outcome. Furthermore, the lack of a discernible pattern in the effects of DMTs on blood immune cells suggests that multiple immune cells can independently modulate the disease.PMID:38461632 | DOI:10.1016/j.intimp.2024.111826

Source: International Immunopharmacology - March 10, 2024 Category: Allergy & Immunology Authors: Jo ão Canto-Gomes Daniela Boleixa Catarina Teixeira Ana Martins da Silva In és González-Suárez Jo ão Cerqueira Margarida Correia-Neves Claudia Nobrega Source Type: research